Search Results - "Marchaim, D."

How to: molecular investigation of a hospital outbreak by Nutman, A., Marchaim, D.

“…Studying hospital outbreaks by using molecular tools, i.e. synthesizing the molecular epidemiology data to its appropriate clinical-epidemiologic context, is…”
Get full text

Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens by Pogue, J.M., Kaye, K.S., Cohen, D.A., Marchaim, D.

“…The past decade has brought a significant rise in antimicrobial resistance, and the ESKAPE pathogens have become a significant threat to public health. Three…”
Get full text

Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System by Pogue, Jason M., Lee, Jiha, Marchaim, Dror, Yee, Victoria, Zhao, Jing J., Chopra, Teena, Lephart, Paul, Kaye, Keith S.

“…Background. Colistin, originally abandoned due to high rates of nephrotoxicity, has been recently reintroduced due to activity against carbapenem-resistant…”
Get full text

The impact of bedside wipes in multi-patient rooms: a prospective, crossover trial evaluating infections and survival by Dadon, M., Chedid, K., Martin, E.T., Shaul, I., Greiver, O., Katz, I., Saadon, H., Alfaro, M., Hod, L., Shorbaje, A., Braslavsky-Siag, A., Moscovici, S., Kaye, K.S., Marchaim, D.

“…Multidrug-resistant organisms (MDROs) are prevalent on high-touch surfaces in multi-patient rooms. To quantify the impact of hanging single-use…”
Get full text

The relationship between the new taxonomy of Streptococcus bovis and its clonality to colon cancer, endocarditis, and biliary disease by Lazarovitch, T., Shango, M., Levine, M., Brusovansky, R., Akins, R., Hayakawa, K., Lephart, P. R., Sobel, J. D., Kaye, K. S., Marchaim, D.

“…Background The nomenclature of Streptococcus bovis has changed. The study aims were to examine and compare the clinical characteristics and outcomes of…”
Get full text

Ten years with colistin: a retrospective case series by Katz, D E, Marchaim, D, Assous, M V, Yinnon, A, Wiener-Well, Y, Ben-Chetrit, E

“…At the Shaare Zedek Medical Center, we have been using colistimethate sodium (CMS) for empiric as well as pathogen-directed treatment. We present our 10-year…”
Get more information

Epidemiology of bacteremia episodes in a single center: increase in Gram-negative isolates, antibiotics resistance, and patient age by Marchaim, D., Zaidenstein, R., Lazarovitch, T., Karpuch, Y., Ziv, T., Weinberger, M.

“…Increased resistance among isolates causing bacteremia constitutes a major challenge to medical practitioners and institutions. Variability between institutes…”
Get full text

Case–control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia by Marchaim, D., Kaye, K.S., Fowler, V.G., Anderson, D.J., Chawla, V., Golan, Y., Karchmer, A.W., Carmeli, Y.

“…Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia is associated with increased mortality. Delay in appropriate antimicrobial therapy (DAAT) is an…”
Get full text

Independent risk factors for the co-colonization of vancomycin-resistant Enterococcus faecalis and methicillin-resistant Staphylococcus aureus in the region most endemic for vancomycin-resistant Staphylococcus aureus isolation by Hayakawa, K., Marchaim, D., Bathina, P., Martin, E. T., Pogue, J. M., Sunkara, B., Kamatam, S., Ho, K., Willis, L. B., Ajamoughli, M., Patel, D., Khan, A., Lee, K. P., Suhrawardy, U., Jagadeesh, K. K., Reddy, S. M. L., Levine, M., Ahmed, F., Omotola, A. M., Mustapha, M., Moshos, J. A., Rybak, M. J., Kaye, K. S.

“…In the majority of cases of vancomycin-resistant Staphylococcus aureus (VRSA), vancomycin-resistant Enterococcus faecalis (VR E. faecalis ) served as the vanA…”
Get full text

Clonal variability of group B Streptococcus among different groups of carriers in southern Israel by MARCHAIM, D, EFRATI, S, MELAMED, R, GORTZAK-UZAN, L, RIESENBERG, K, ZAIDENSTEIN, R, SCHLAEFFER, F

“…A high prevalence of maternal group B Streptococcus (GBS) carriage and an extremely low incidence of invasive neonatal disease have been reported from southern…”
Get full text

Molecular and Epidemiologic Study of Polyclonal Outbreaks of Multidrug‐Resistant Acinetobacter baumannii Infection in an Israeli Hospital by Marchaim, Dror, Navon‐Venezia, Shiri, Leavitt, Azita, Chmelnitsky, Inna, Schwaber, Mitchell J., Carmeli, Yehuda

“…Objectives. To perform a molecular and epidemiologic investigation of multidrug‐resistant (MDR) Acinetobacter baumannii in an institution were polyclonal…”
Get full text

Population structure of group B streptococcus from a low-incidence region for invasive neonatal disease by Bisharat, Naiel, Jones, Nicola, Marchaim, Dror, Block, Colin, Harding, Rosalind M, Yagupsky, Pablo, Peto, Tim, Crook, Derrick W

“…1 Department of Medicine C, Ha'Emek Medical Center, Afula, Israel 2 Department of Microbiology, Nuffield Department of Clinical Laboratory Sciences, John…”
Get full text

Serious consequences to the use of cephalosporins as the first line of antimicrobial therapy administered in hemodialysis units by Marchaim, Dror, Lazarovitch, Zipora, Efrati, Shai, Dishy, Victor, Weissgarten, Joshua, Boldur, Ida, Zaidenstein, Ronit

“…The dramatic spread of vancomycin-resistant enterococci (VRE) among hemodialysis (HD) patients led to the replacement of vancomycin with cephalosporins as part…”
Get more information

Risk factors for carriage of group B streptococcus in southern Israel by Marchaim, Dror, Hallak, Mordechai, Gortzak-Uzan, Limor, Peled, Nechama, Riesenberg, Klaris, Schlaeffer, Francisc

“…In southern Israel, a discrepancy between a relatively high prevalence of Group B streptococcus maternal carriage (12.3%) and a very low incidence of neonatal…”
Get full text

Cell wall proteins of group B Streptococcus and low incidence of neonatal disease in southern Israel by MARCHAIM, Dror, HALLAK, Mordechai, GORTZAK-UZAN, Limor, PELED, Nechama, RIESENBERG, Klaris, SCHLAEFFER, Francisc

“…To determine the maternal group B Streptococcus (GBS) prevalence of carriage and serotype distribution and the neonatal disease incidence to formulate a policy…”
Get full text

The Continuing Plague of Extended-spectrum β-lactamase–producing Enterobacteriaceae Infections by Adler, Amos, MD, Katz, David E., MD, MPH, Marchaim, Dror, MD

“…Antimicrobial resistance is a common iatrogenic complication of modern life and medical care. One of the most demonstrative examples is the exponential…”
Get full text

Risk factors for bloodstream infection caused by extended-spectrum β-lactamase–producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime by Chopra, Teena, MD, MPH, Marchaim, Dror, MD, Johnson, Paul C., MD, Chalana, Indu K., MD, Tamam, Zeinab, MD, Mohammed, Mazin, MD, Alkatib, Shatha, MD, Tansek, Ryan, MD, Chaudhry, Khawar, MD, Zhao, Jing J., PharmD, Pogue, Jason M., PharmD, Kaye, Keith S., MD

“…Background Extended-spectrum β-lactamase (ESBL)–producing pathogens represent increasing challenges to physicians because of rising prevalence, high mortality,…”
Get full text

Multidrug-Resistant Gram-Negative Bacilli by Adler, Amos, MD, Friedman, N. Deborah, MBBS, MD, MPH, Marchaim, Dror, MD

“…Antimicrobial resistance is a common iatrogenic complication of both modern life and medical care. Certain multidrug resistant and extensively drug resistant…”
Get full text

Outcomes of carbapenem-resistant Enterobacteriaceae isolation: Matched analysis by Bogan, Christopher, BS, Kaye, Keith S., MD, MPH, Chopra, Teena, MD, MPH, Hayakawa, Kayoko, MD, PhD, Pogue, Jason M., PharmD, Lephart, Paul R., PhD, Bheemreddy, Suchitha, MD, Lazarovitch, Tsilia, PhD, Zaidenstein, Ronit, MD, Perez, Federico, MD, Bonomo, Robert A., MD, Marchaim, Dror, MD

“…Background Carbapenem-resistant Enterobacteriaceae (CRE) isolation is associated with poor outcomes. The matched cohort study design enables investigation of…”
Get full text

Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections by Ku, Kimberly, BS, Pogue, Jason M., PharmD, Moshos, Judy, MT, Bheemreddy, Suchitha, MD, Wang, Yujing, BS, Bhargava, Ashish, MD, Campbell, Michelle, BS, Khandker, Namir, BS, Lephart, Paul R., PhD, Chopra, Teena, MD, Hayakawa, Kayoko, MD, PhD, Martin, Emily T., PhD, Abreu-Lanfranco, Odaliz, MD, Dhar, Sorabh, MD, Kaye, Keith S., MD, MPH, Marchaim, Dror, MD

“…Backgound Therapeutic options are limited for infections because of Acinetobacter baumannii and carbapenem-resistant Enterobacteriaceae (CRE). Study aim was to…”
Get full text